Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Optomed’s Board has resolved upon a new option plan

Optomed Plc Stock Exchange Release 17 May 2024 at 10.30, Helsinki Optomed’s Board has resolved upon a new option plan Optomed’s board of directors has resolved upon a new option plan. The resolution is based on the authorization given by the general meeting of 10 May 2024.   Option plan 2024A: The total number of options is 300,000 and each option entitled to one share of the company. The options are offered to the CEO and certain key employees. The purpose of the plan is to retain and incentifize the CEO and other key employees. The subscription price is EUR 4.62. The

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS17 May 2024 at 09:55NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Johan LarssonPosition: Chief Executive Officer Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 63136/5/4 ____________________________________________Transaction date: 2024-05-15Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction details(1): Volume:

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS17 May 2024 at 09:50NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Holding Investment Förvaltning i Luleå ABPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive Officer(2):Person Discharging Managerial Responsibilities In IssuerName: Mikael RitolaPosition: Other senior managerIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL

Clean Industry Solutions Holding Europe AB: Quarterly Report January-March 2024

Q1 from 01-01-2024 to 31-03-2024 (01-01-2023 to 31-03-2023)The report can be found here:https://cleanindustrysolutions.com/en/investor-relations/financial-reports/ The period in brief – financial summary for the first quarter · Income dropped by -94 % to SEK 0.1 million · Other operating income amounted to SEK 0.1 million · Operating expenses plus cost of sales for the first quarter amounted to SEK -2.4 million · Operating result (EBIT) for the first  quarter amounted to SEK -2.2 million · Earnings per share, before and after dilution, for the first quarter amounted to

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS17 May 2024 at 09:45NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive OfficerIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 63124/4/6 ____________________________________________Transaction date: 2024-05-13

Kährs at Southern Sweden Design Days 23-26 May

Welcome to a sustainable journey in pastel with Kährs at Southern Sweden Design Days! Kährs is an official partner at the international design festival in Malmö, which this year has the theme "Care". Kährs is represented through an exhibition in the main venue for the event, Lokstallarna, and is also part of the program through a seminar where Sustainability Manager Therése Gerdman and Design Manager Petra Lundblad talk on the theme design, sustainability, circularity with the title "A sustainable journey in pastel - how we work with circularity ". Day and time for Kährs'

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS17 May 2024 at 09:35NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Anders BergPosition: Member of the Board/Deputy member Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 63121/5/4 ____________________________________________Transaction date: 2024-05-16Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction details(1):

Notice of annual general meeting in Biosergen AB

The shareholders of Biosergen AB, Reg. No. 559304-1295, (the “Company”) are invited to attend the annual general meeting to be held on Friday June 14, 2024, at Fogdevreten 2A, SE-171 65 Solna, at 11:00.Right to participate and notice of participationShareholders wishing to participate in the annual general meeting must: · partly be listed in the Company’s share register kept by Euroclear Sweden AB as of Wednesday June 5 2024; and · partly have given a notice of their intent to participate to the Company no later than on Monday June 10 2024 by post to Advokatfirman Hammarskiöld &

Perpetua Medical publishes interim report January - March 2024

Important milestones pave the way for a serial acquiring business. Perpetua Medical AB (publ) announces today that the interim report for the period January – March 2024 has been published. The interim report is attached as a PDF and is available on the company’s website:https://perpetuamedical.se/investor-relations-2/financial-reports/ (Swedish only). First Quarter January 1 – March 31 2024 · Consolidated net sales for the first quarter amounted to 1 373 (4 729) KSEK. · Operating profit for the first quarter amounted to SEK 2,041 (-4,299) KSEK. · Net earnings per share

Cereno Scientific presents at ABGSC Investor Days, May 23

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, is scheduled to present at the ABGSC Investor Days in Stockholm on May 23, 2024, at 15:15. CEO Sten R. Sörensen will present the Company’s pipeline and meet with potential investors.Read more about the Investor Days on the ABGSC website here . For further information, please contact: Henrik Westdahl, Director IR & Communications Email: henrik.westdahl@

InCoax Networks AB Annual Report 2023

InCoax's sales growth continued in 2023, and the financial goal to double the sales compared to 2022 was exceeded by a margin. The partnership established with Nokia lays the foundation for continued strong growth.Financial performance · Net sales amounted to SEK 59,619,447 (25,922,260), corresponding to an increase of 130 percent compared to the same period last year. · The operating result for the year amounted to SEK -16,729,885 (–22,329,647), an improvement driven by higher sales in 2023. · The year's result after tax amounted to SEK -16,980,631 (–22,815,010), which results

PHI secures a loan facility of in total SEK 7 million

Phase Holographic Imaging PHI AB ("PHI" or the "Company") announces that the Company has secured a loan facility of in total SEK 7 million from Bizcap AB, and from that loan facility decided to draw a tranche of SEK 4.5 million.Loan facility PHI has signed an agreement with Bizcap AB regarding a loan facility of in total SEK 7 million, making it possible for PHI to draw two loan tranches of SEK 4.5 million and SEK 2.5 million respectively. PHI has decided to draw upon a first tranche of SEK 4.5 million. The loan facility has a setup fee of 5 percent and the activated loan runs with an

GomSpace Q1 2024 Trading Statement

GomSpace releases its Q1 2024 trading statement and maintains the guidance for positive free cashflow in 2[nd] half of 2024.FIRST QUARTER OF 2024 (2023) · Order intake increased to T.SEK 57,112 (33,454) · Net revenue is T.SEK 50,162 (78,150) · Free cashflow this quarter is T.SEK -12,053 (-42,406) · Operating profit (EBIT) decreased to negative T.SEK -22,199 (negative 14,078) · Earnings per share were negative SEK 0.18 (negative SEK 0.24) A full half-year report will be delivered on August 23, 2024. Q3 Trading Statement will be moved up 4 weeks from 27 November 2024 to

Esmaeilzadeh Holding publishes net asset value as of 30 April 2024

As of 30 April 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 7.13 billion (SEK 7.16 billion as of 31 March 2024), corresponding to a net asset value per share of SEK 9,092 (SEK 9,129 as of 31 March 2024).[1]  For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group For press related enquires, please contact: Michaela Abercrombie Simpson, Head of Communication Phone: +46 736 301 403 The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 17 May 2024.

Experience Iceland's unique nature and recconnect with the elements

Nestled within a sprawling 1,200-acre estate in the Icelandic wilderness of Hvalfjörður, Hvammsvík Hot Springs stands as a testament to sustainable luxury and natural beauty. This unique geothermal resort features eight naturally formed hot spring pools, a cozy bar and bistro, and four rustic, high-end lodges. Creative Director and Co-Owner Gríma Thorarensen shares the inspiring journey of developing Hvammsvík into a serene retreat that encourages guests to reconnect with nature, blending modern sustainable materials with a rustic, biophilic design.Iceland's newest natural, geothermal

Gradientech: Interim report January–March 2024

Gradientech AB (publ) interim report for Q1 2024 is now available on the company's website www.gradientech.se.First quarter 2024 · Net sales amounted to SEK 485 thousand (380). · Net profit/loss amounted to SEK -15,648 thousand (-18,063). · Earnings per share before and after dilution were SEK -0.68 (-1.08). · Cash flow from operating activities amounted to SEK -14,813 thousand (-18,068). · Cash and cash equivalents amounted to SEK 21,336 thousand (25,993) as of March 31, 2024. · Equity amounted to SEK 32,800 thousand (40,731) as of March 31, 2024. · In January 2024

Kamux Corporation’s Interim Report for January 1—March 31, 2024: Revenue grew and adjusted operating profit increased significantly, actions in Sweden are progressing

Kamux Corporation, Interim Report, 17.5.2024 at 9:00 Kamux Corporation’s Interim Report for January 1—March 31, 2024: Revenue grew and adjusted operating profit increased significantly, actions in Sweden are progressing This is a summary of Kamux Corporation’s Interim Report for January 1—March 31, 2024. The complete report is attached to this release and is also available at the company website at kamux.com . The figures in parentheses refer to the comparison period, i.e., the same period in the previous year, unless stated otherwise. January–March in

The Minister for Rural Affairs in a meeting with Lantmännen and Spendrups – about sustainable innovation, increased food production and strengthened preparedness

Minister for Rural Affairs Peter Kullgren visited Lantmännen's future farm in Bjertorp. Spendrups and Lantmännen presented different ways to develop Swedish food production, drive a sustainable transition and propose measures to make Swedish agriculture as strong, profitable and robust as possible.   "It was gratifying to meet Peter Kullgren again, not least where exciting things are happening – on our farm of the future. The meeting was a good opportunity to show practical examples of our innovation work with the aim of increasing food production in a sustainable way. We also reiterated

Nordec has signed a contract with Skanska and Haehre consisting of 11 steel bridges.

Nordec has been selected as a provider for a challenging project OPS Hålogalandsvegen in North of Norway, due to its reliability and high-quality standards. The total contracts include the construction and installation of steel structures for 11 bridges.Nordec Group Oy press release 17.05.2024 at 09.00 EET UTC+3   Nordec has signed a contract with Skanska and Haehre consisting of 11 steel bridges.   Nordec has been selected as a provider for a challenging project OPS Hålogalandsvegen in North of Norway, due to its reliability and high-quality standards. The total contracts

Safello publishes Interim Report for the First Quarter 2024 and delivers a historically strong quarter

Stockholm, 17 May 2024 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the first quarter (1 January–31 March) 2024. The report is attached hereto and can be found on safello.com/ir . Summary of the first quarter (Jan-Mar 2024) · Net turnover increased by 40 % and amounted to SEK 193.1 million (138.1). · Gross profit increased by 24 % and amounted to SEK 14.1 million (11.4), including a profit from the sale of long-term crypto assets of SEK 0.7 million (0.0). Why gross profit increased less than the net

Mydecine Provides Bl-Weekly Status Report

MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, May 17, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) provides this update on the status of a management cease trade order granted on May 2, 2024 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203").   On May 3, 2024, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’

Interim Report for the period January – March 2024

First BrainTransporter technology agreement signed  Events during the first quarter 2024 · Leqembi® was approved for the treatment of Alzheimer's disease in China – launch planned for July 2024 · The European Medicines Agency (EMA) announced that its deliberations on lecanemab regarding the Marketing Authorisation Application has been rescheduled due to procedural reasons Events after the end of the period · BioArctic’s partner Eisai submitted a supplemental Biologics License Application (sBLA) for less frequent intravenous (IV) maintenance dosing with lecanemab to the

Sales results for Tender 6 FY 2024

/     17 May 2024  LSE: PDL     Petra Diamonds Limited (Petra or the Company)   Sales results for Tender 6 FY 2024     Richard Duffy, Chief Executive Officer of Petra, commented:   “Our sixth tender cycle yielded US$44 million from the sale of 371kcts. Like-for-like[1] prices were marginally down through this seasonally quiet period, being 2.6% lower than Tender 5, with demand slightly muted due to Indian holidays and the continued slow recovery in the Chinese market. We continue to see evidence of stabilisation in the market and are

There are no items matching the current filter
There are no more items matching the current filter
Back to top